Summary
- Current Price
- As of today, SUPN price is $54.27, down -2.36% on
- Current Price All-Time High
- SUPN price is currently -11.40% below its historical high of $61.25 set on
- Market Cap
- SUPN current market cap is $3B, up +75.21% over the past 365 days
- PE Ratio
- SUPN PE ratio is unknown
- Revenue
- SUPN current annual revenue is $718.95M, up +8.63% year-over-year
- Next Earnings
- The next earnings release for SUPN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Supernus Pharmaceuticals, Inc. |
| Ticker | NASDAQ: SUPN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | supernus.com |
| Employees | 674 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $54.27 | |
| Price, 1D Change | -2.36% | |
| $3B | ||
| - | ||
| - | ||
| 0.45 | ||
| $719M | ||
| Revenue, 1Y Change | +8.63% | |
| -$0.68 | ||
| EPS, 1Y Change | -151.73% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.68 | ||
| EPS Estimate | N/A | $2.37 |
| EPS Est. Change | N/A | +446.32% |
| $718.95M | ||
| Revenue Estimate | N/A | $865.01M |
| Revenue Est. Change | N/A | +20.32% |
| Current Price | $54.27 | |
| Price Target | - | $65.00 |
| Price Tgt. Change | - | +19.77% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.87 | $1.32 | -54.06% | |
| $2.63 | -$0.68 | -126.02% | |
| $2.37 | N/A | +446.32% | |
| $4.22 | N/A | +717.95% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $642.90M | $661.82M | +2.94% | |
| $702.52M | $718.95M | +2.34% | |
| $865.01M | N/A | +20.32% | |
| $1.02B | N/A | +42.10% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $54.27 | |
| $44.10 | ||
| SMA 200 vs Price | -18.74% | |
| $51.03 | ||
| SMA 50 vs Price | -5.97% | |
| 0.45 | ||
| $2.24 | ||
| 58.04 | ||
| 44.58% | ||
| 35.41% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $718.95M | ||
| -$0.68 | ||
| $644.39M | ||
| 89.63% | ||
| -$36.86M | ||
| -5.13% | ||
| -$38.55M | ||
| -5.36% | ||
| - |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.03 | ||
| 1.90 | ||
| 1.66 | ||
| - | ||
| - | ||
| 5.94 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 4.33 | ||
| 2.93 | ||
| 53.58 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.06B | ||
| $308.67M | ||
| $1.45B | ||
| $644.18M | ||
| $390.93M | ||
| $338.17M | ||
| $30.37M | ||
| - | ||
| $107.80M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $757.50M | ||
| $681.25M | ||
| $74.56M | ||
| $0.00 | ||
| - | ||
| $0.00 | ||
| -$10.48M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Stifel | → | |
| B of A Securities | ||
| TD Cowen | → | |
| Piper Sandler | → | |
| Cantor Fitzgerald | → | |
| Piper Sandler | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with SUPN
FAQ
What is the ticker symbol for Supernus Pharmaceuticals, Inc.?
The ticker symbol for Supernus Pharmaceuticals, Inc. is NASDAQ:SUPN
Does Supernus Pharmaceuticals, Inc. pay dividends?
No, Supernus Pharmaceuticals, Inc. does not pay dividends
What sector is Supernus Pharmaceuticals, Inc. in?
Supernus Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Supernus Pharmaceuticals, Inc. in?
Supernus Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Supernus Pharmaceuticals, Inc. based in?
Supernus Pharmaceuticals, Inc. is headquartered in United States
When did Supernus Pharmaceuticals, Inc. go public?
Supernus Pharmaceuticals, Inc. initial public offering (IPO) was on May 1, 2012
Is Supernus Pharmaceuticals, Inc. in the S&P 500?
No, Supernus Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Supernus Pharmaceuticals, Inc. in the NASDAQ 100?
No, Supernus Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Supernus Pharmaceuticals, Inc. in the Dow Jones?
No, Supernus Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Supernus Pharmaceuticals, Inc. last earnings report?
Supernus Pharmaceuticals, Inc.'s most recent earnings report was on February 24, 2026
When does Supernus Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Supernus Pharmaceuticals, Inc. is May 5, 2026
Data Sources & References
- SUPN Official Website www.supernus.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1356576/000135657626000004/0001356576-26-000004-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1356576/000135657626000011/0001356576-26-000011-index.htm
- SUPN Profile on Yahoo Finance finance.yahoo.com/quote/SUPN
- SUPN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/supn